T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 99-107

  Müller, Ralf ^a   Dahler, Christiane ^a   Möbs, Christian ^a   Wenzel, Elke ^a   Eming, Rüdiger ^a   Messer, Gerald ^b   Niedermeier, Andrea ^a,b   Hertl, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoantibody; ; Collagen VII; ; ELISA; ; ELISPOT; ; Epidermolysis bullosa; ; Epitope; ; Immunoadsorption; ; Immunoblot; Rituximab; ; T cell;

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 7; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SERUM; T LYMPHOCYTE;

AUTOANTIBODIES; B-LYMPHOCYTES; BLOTTING, WESTERN; CLONING, MOLECULAR; COHORT STUDIES; COLLAGEN TYPE VII; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; EPITOPES; HUMANS; IMMUNOGLOBULIN G; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 77649233701     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.12.010     Document Type: Article

References (31)

1. Chen M., Hallel-Halevy D., Nadelman C., and Woodley D.T. Epidermolysis bullosa acquisita. In: Hertl M. (Ed). Autoimmune Diseases of the Skin (2005), Springer, Wien 109-132
2. Yancey K.B. The pathophysiology of autoimmune blistering diseases. J. Clin. Invest. 115 (2005) 825-828
3. Woodley D.T., Remington J., and Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin. Rev. Allergy Immunol. 33 (2007) 78-84
4. Woodley D.T., O'Keefe E.J., Reese M.J., Mechanic G.L., Briggaman R.A., and Gammon W.R. Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J. Invest. Dermatol. 86 (1986) 668-672
5. Gammon W.R., Murrell D.F., Jenison M.W., Padilla K.M., Prisayanh P.S., Jones D.A., Briggaman R.A., and Hunt S.W.D. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J. Invest. Dermatol 100 (1993) 618-622
6. Lapiere J.C., Woodley D.T., Parente M.G., Iwasaki T., Wynn K.C., Christiano A.M., and Uitto J. Epitope mapping of type VII collagen: identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J. Clin. Invest. 92 (1993) 189-1831
7. Tanaka T., Furukawa F., and Imamura S. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J. Invest. Dermatol. 102 (1994) 706-709
8. Chen M., Marinkovich M.P., Jones J.C., O'Toole E.A., Li Y.Y., and Woodley D.T. NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J. Invest. Dermatol. 112 (1999) 177-183
9. Sitaru C., Kromminga A., Hashimoto T., Bröcker E.B., and Zillikens D. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am. J. Pathol 161 (2002) 301-311
10. Shimanovich I., Mihai S., Oostingh G.J., Ilenchuk T.T., Bröcker E.B., Opdenakker G., Zillikens D., and Sitaru C. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 204 (2004) 519-527
11. Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp. Dermatol. 16 (2007) 520-531
12. Woodley D.T., Chang C., Saadat P., Ram R., Liu Z., and Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J. Invest. Dermatol. 124 (2005) 958-964
13. Woodley D.T., Ram R., Doostan A., Bandyopadhyay P., Huang Y., Remington J., Hou Y., Keene D.R., Liu Z., and Chen Z.M. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J. Invest. Dermatol. 126 (2006) 1323-1330
14. Sitaru C., Mihai S., Otto C., Chiriac M.T., Hausser I., Dotterweich B., Saito H., Rose C., Ishiko A., and Zillikens D. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J. Clin. Invest. 115 (2005) 870-878
15. Sitaru C., Chiriac M.T., Mihai S., Büning J., Gebert A., Ishiko A., and Zillikens D. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J. Immunol. 177 (2006) 3461-3468
16. Gammon W.R., Kowalewski C., Chorzelski T.P., Kumar V., Briggaman R.A., and Beutner E.H. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J. Am. Acad. Dermatol. 22 (1990) 664-670
17. Niedermeier A., Eming R., Pfütze M., Neumann C.R., Happel C., Reich K., and Hertl M. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibody). Arch. Dermatol. 143 (2007) 192-198
18. Pfütze M., Niedermeier A., Hertl M., and Eming R. Introducing a novel autoimmune bullous skin disorder intensity core (ABSIS) in pemphigus. Eur. J. Dermatol. 17 (2007) 4-11
19. Müller R., Svoboda V., Wenzel E., Gebert S., Hunzelmann N., Müller H.H., and Hertl M. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Exp. Dermatol. 15 (2006) 606-614
20. Hofmann S., Thoma-Uszynski S., Hunziker T., Bernard P., Koebnick C., Stauber A., Schuler G., Borradori L., and Hertl M. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2-and COOH-terminal regions of the BP180 ectodomain. J. Invest. Dermatol. 119 (2002) 1065-1073
21. Thoma-Uszynski S., Uter W., Schwietzke S., Hofmann S., Hunziker T., Bernard P., Treudler R., Zouboulis C.C., Schuler G., Borradori L., and Hertl M. BP230-and BP180-specific auto-antibodies in bullous pemphigoid. J. Invest. Dermatol. 122 (2004) 1413-1422
22. Lin M.S., Swartz S.J., Lopez A., Ding X., Fernandez-Vina M.A., Stastny P., Fairley J.A., and Diaz L.A. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J. Clin. Invest. 99 (1997) 31-34
23. Lin M.S., Gharia M.A., Swartz S.J., Diaz L.A., and Giudice G.J. Identification andcharacterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis. J. Immunol. 162 (1999) 4991-4997
24. Lin M.S., Fu C.L., Olague-Marchan M., Hacker M.K., Zillikens D., Giudice G.J., and Fairley J.A. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Clin. Immunol. 102 (2002) 310-319
25. Büdinger L., Borradori L., Yee C., Eming R., Ferencik S., Grosse-Wilde H., Merk H.F., Yancey K.B., and Hertl M. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest. 102 (1998) 2082-2089
26. Veldman C.M., Gebhard K.L., Uter W., Wassmuth R., Grötzinger J., Schultz E., and Hertl M. M, T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J. Immunol. 172 (2004) 3883-3892
27. Thoma-Uszynski S., Uter W., Schwietzke S., Schuler G., Borradori L., and Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J. Immunol. 176 (2006) 2015-2023
28. Eming R., Büdinger L., Riechers R., Christensen O., Bohlen H., Kalish R., and Hertl M. M, Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Br. J. Dermatol. 143 (2000) 1279-1282
29. Hertl M., Eming R., and Veldman C. T cell control in autoimmune bullous skin disorders. J. Clin. Invest. 116 (2006) 1159-1166
30. Chen M., Chan L.S., Cai X., O'Toole E.A., Sample J.C., and Woodley D.T. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J. Invest. Dermatol. 108 (1997) 68-72
31. Hallel-Halevy D., Nadelman C., Chen M., and Woodley D.T. Epidermolysis bullosa acquisita: update and review. Clin. Dermatol. 19 (2001) 712-718